Psychotropic medications sales during COVID-19 outbreak in Italy changed according to the pandemic phases and related lockdowns
- 16 October 2021
- journal article
- research article
- Published by Elsevier in Public Health
- Vol. 201, 75-77
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Assessment of Psychotropic Drug Prescribing Among Nursing Home Residents in Ontario, Canada, During the COVID-19 PandemicJAMA Internal Medicine, 2021
- The prevalence of psychiatric comorbidities during the SARS and COVID-19 epidemics: a systematic review and meta-analysis of observational studiesJournal of Affective Disorders, 2021
- Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analysesGlobalization and Health, 2021
- Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysisJournal of Affective Disorders, 2021
- Antidepressants, primary care, and adult mental health services in England during COVID-19The Lancet Psychiatry, 2021
- Global Storm of Stress-Related Psychopathological Symptoms: A Brief Overview on the Usefulness of Virtual Reality in Facing the Mental Health Impact of COVID-19Cyberpsychology, Behavior, and Social Networking, 2020
- COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine – We Should be PreparedDisaster Medicine and Public Health Preparedness, 2020
- The COVID-19 pandemic brings a second wave of social isolation and disrupted servicesEuropean Archives of Psychiatry and Clinical Neuroscience, 2020